Doctor Matthew
SEC CIK 1844838 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RGS | REGIS CORP | Pres, CEO, Dir | 19.6K | — | — | 9 | 2021-11-05 | 2024-11-22 |
Most active insiders at RGS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MERRIMAN MICHAEL J | Dir | — | $14.0K |
| 2 | Alfano Andrew | Dir | — | — |
| 3 | MacDonald Keelee | Senior VP-Franchise Ops | — | — |
| 4 | Charters William | Dir | — | — |
| 5 | DeVore Michelle St. Lawrence | SVP, Marketing | — | — |
| 6 | Suarez James Raymon | EVP, Company Ops | — | — |
| 7 | ANDREWS LOCKIE | Dir | — | — |
| 8 | Lintonsmith Susan | Pres, CEO, Dir | — | — |
| 9 | Ferranti Michael Heath | EVP Brand Ops | — | — |
| 10 | Benacci Nancy Cunningham | Dir | — | — |
Doctor Matthew made no open-market trades at RGS in the last 12 months.
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-26 | 2024-11-22 | RGS | REGIS CORP | Doctor Matthew | Pres, CEO, Dir | A - Grant | $0.00 | +16.5K | 19.6K | +535% | $0 | |
| A | 2024-11-19 | 2024-11-05 | RGS | REGIS CORP | Doctor Matthew | Pres, CEO, Dir | F - Tax | $23.37 | -547 | 3,084 | -15% | -$12.8K |
| 2024-11-07 | 2024-11-05 | RGS | REGIS CORP | Doctor Matthew | Pres, CEO, Dir | F - Tax | $23.37 | -339 | 3,292 | -9% | -$7,922 | |
| 2024-02-09 | 2024-02-08 | RGS | REGIS CORP | Doctor Matthew | Pres, CEO, Dir | F - Tax | $12.35 | -211 | 76.7K | -0.3% | -$2,606 | |
| 2023-11-08 | 2023-11-06 | RGS | REGIS CORP | Doctor Matthew | Pres, CEO, Dir | F - Tax | $0.53 | -3,648 | 76.9K | -5% | -$1,933 | |
| 2022-11-09 | 2022-11-07 | RGS | REGIS CORP | Doctor Matthew | Pres, CEO, Dir | F - Tax | $1.26 | -2,837 | 80.5K | -3% | -$3,575 | |
| 2022-03-02 | 2022-02-08 | RGS | REGIS CORP | Doctor Matthew | Interim CEO | F - Tax | $1.65 | -4,343 | 83.4K | -5% | -$7,166 | |
| A | 2021-11-16 | 2021-11-05 | RGS | REGIS CORP | Doctor Matthew | EVP, Chief Strategy Off | A - Grant | $0.00 | +46.3K | 87.7K | +112% | $0 |
| DM | 2021-11-09 | 2021-11-05 | RGS | REGIS CORP | Doctor Matthew | EVP, Chief Strategy Off | A - Grant | $0.7185 | +47.0K | 76.1K | +161% | +$33.8K |
Purchase Sale Sale after option exercise All abbreviations